ALNEV — Neovacs SA Cashflow Statement
0.000.00%
Last trade - 00:00- €0.00m
- -€0.20m
- €0.29m
Annual cashflow statement for Neovacs SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | — | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.14 | -11.8 | -3.55 | -8.74 | -32.9 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.167 | 0 | 0.25 | 21.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.312 | 1.76 | -1.37 | 1.56 | 0.542 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.65 | -9.91 | -4.45 | -1.91 | -3.6 |
| Capital Expenditures | -0.207 | -0.352 | -0.158 | -0.205 | -0.08 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.016 | -18.5 | -31.4 | -10.9 | 1.53 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.223 | -18.8 | -31.6 | -11.1 | 1.45 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.6 | 51.7 | 9.99 | 6.79 | 1.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.78 | 23 | -26 | -6.2 | -0.452 |